Arnthor Aevarsson

Title: Arnthor Aevarsson: Innovator in RNA Technology

Introduction

Arnthor Aevarsson is a notable inventor based in Hveragerdi, Iceland. He has made significant contributions to the field of RNA technology, holding a total of 3 patents. His work focuses on the development of novel RNA ligases derived from bacteriophages, which have important applications in molecular biology.

Latest Patents

Among his latest patents is the "Thermostable RNA ligase from thermus phage." This invention describes an RNA ligase derived from bacteriophage TS2126, which infects nucleic acids comprising nucleotide sequences of open reading frames (ORFs) and the polypeptides encoded by these nucleic acids. Another significant patent is the "RNA ligase of bacteriophage RM 378," which details a novel bacteriophage RM 378, including the nucleic acids of its genome, the nucleotide sequences of its open reading frames (ORFs), and the polypeptides encoded by these nucleic acids.

Career Highlights

Arnthor has worked with Prokaria Ltd. and Prokaria Ehf., where he has contributed to advancing research in RNA technologies. His innovative approaches have positioned him as a key figure in the field.

Collaborations

He has collaborated with notable colleagues such as Gudmundur Oli Hreggvidsson and Sigridur Hjörleifsdottir, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Arnthor Aevarsson's contributions to RNA technology through his patents and collaborations highlight his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in molecular biology.